181 related articles for article (PubMed ID: 32823610)
1. EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice.
Whitehurst KS; Chan VA; Estes HK; Valsaraj S; Kent S; Sharma UM; Chase RC; Bhuiyan M; Virag JAI
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823610
[TBL] [Abstract][Full Text] [Related]
2. EphA2-receptor deficiency exacerbates myocardial infarction and reduces survival in hyperglycemic mice.
DuSablon A; Kent S; Coburn A; Virag J
Cardiovasc Diabetol; 2014 Aug; 13():114. PubMed ID: 25166508
[TBL] [Abstract][Full Text] [Related]
3. EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice.
DuSablon A; Parks J; Whitehurst K; Estes H; Chase R; Vlahos E; Sharma U; Wert D; Virag J
PLoS One; 2017; 12(12):e0189307. PubMed ID: 29236774
[TBL] [Abstract][Full Text] [Related]
4. Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.
Dries JL; Kent SD; Virag JA
J Physiol; 2011 Apr; 589(Pt 7):1725-40. PubMed ID: 21282286
[TBL] [Abstract][Full Text] [Related]
5. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
Yang XY; Zhu WJ; Jiang H
Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy.
O'Neal WT; Griffin WF; Kent SD; Faiz F; Hodges J; Vuncannon J; Virag JA
Front Physiol; 2014; 5():132. PubMed ID: 24795639
[TBL] [Abstract][Full Text] [Related]
7. Intracardiac administration of ephrinA1-Fc preserves mitochondrial bioenergetics during acute ischemia/reperfusion injury.
Torres MJ; McLaughlin KL; Renegar RH; Valsaraj S; Whitehurst KS; Sharaf OM; Sharma UM; Horton JL; Sarathy B; Parks JC; Brault JJ; Fisher-Wellman KH; Neufer PD; Virag JAI
Life Sci; 2019 Dec; 239():117053. PubMed ID: 31733316
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional signalling between EphA2 and ephrinA1 increases tubular cell attachment, laminin secretion and modulates erythropoietin expression after renal hypoxic injury.
Rodriguez S; Rudloff S; Koenig KF; Karthik S; Hoogewijs D; Huynh-Do U
Pflugers Arch; 2016 Aug; 468(8):1433-48. PubMed ID: 27228995
[TBL] [Abstract][Full Text] [Related]
9. All-trans retinoic acid attenuates bleomycin-induced pulmonary fibrosis via downregulating EphA2-EphrinA1 signaling.
Leem AY; Shin MH; Douglas IS; Song JH; Chung KS; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
Biochem Biophys Res Commun; 2017 Sep; 491(3):721-726. PubMed ID: 28743499
[TBL] [Abstract][Full Text] [Related]
10. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
[TBL] [Abstract][Full Text] [Related]
11. Protection by the Eph-Ephrin System Against Mesenteric Ischemia-Reperfusion Injury.
Vivo V; Zini I; Cantoni AM; Grandi A; Tognolini M; Castelli R; Ballabeni V; Bertoni S; Barocelli E
Shock; 2017 Dec; 48(6):681-689. PubMed ID: 28472014
[TBL] [Abstract][Full Text] [Related]
12. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
[TBL] [Abstract][Full Text] [Related]
13. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma.
Li X; Wang L; Gu JW; Li B; Liu WP; Wang YG; Zhang X; Zhen HN; Fei Z
Tumour Biol; 2010 Oct; 31(5):477-88. PubMed ID: 20571968
[TBL] [Abstract][Full Text] [Related]
15. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
[TBL] [Abstract][Full Text] [Related]
17. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.
Purcell BP; Barlow SC; Perreault PE; Freeburg L; Doviak H; Jacobs J; Hoenes A; Zellars KN; Khakoo AY; Lee T; Burdick JA; Spinale FG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H814-H825. PubMed ID: 29979624
[TBL] [Abstract][Full Text] [Related]
18. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
Castillero E; Akashi H; Najjar M; Ji R; Brandstetter LM; Wang C; Liao X; Zhang X; Sperry A; Gailes M; Guaman K; Recht A; Schlosberg I; Sweeney HL; Ali ZA; Homma S; Colombo PC; Ferrari G; Schulze PC; George I
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H378-H390. PubMed ID: 31886717
[TBL] [Abstract][Full Text] [Related]
19. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
20. Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
Nasreen N; Mohammed KA; Lai Y; Antony VB
Cancer Lett; 2007 Dec; 258(2):215-22. PubMed ID: 17949899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
